Skip to main content
Equibles

Erste Asset Management GmbH

Position in EDIT — Editas Medicine, Inc.

CIK 2024532 VIENNA, C4
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$745,200
+$694,050 QoQ
Shares Held
230,000
+1433.3% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 216 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. EDIT ranks #54 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AGIO
Agios Pharmaceuticals, Inc.
 2,154,900 $79,968,339
2 MDGL
Madrigal Pharmaceuticals, Inc.
 110,210 $59,177,259
3 SRPT
Sarepta Therapeutics, Inc.
 2,568,945 $46,163,941
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 76,558 $38,028,654
5 ROIV
Roivant Sciences Ltd.
 834,000 $29,515,260
6 DNA
Ginkgo Bioworks Holdings, Inc.
 2,536,939 $25,141,065
7 REGN
Regeneron Pharmaceuticals, Inc.
 38,716 $24,140,974
8 MIRM
Mirum Pharmaceuticals, Inc.
 205,000 $23,999,350

All Filings in EDIT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $745,200 230,000
2024-09-30 $51,150 15,000
2024-06-30 $70,050 15,000
2024-03-31 $111,300 15,000
2023-12-31 $151,950 15,000
2023-09-30 $117,000 15,000
2023-06-30 $123,450 15,000
2023-03-31 $108,750 15,000
2022-12-31 $133,050 15,000
2022-09-30 $183,600 15,000
2022-06-30 $177,450 15,000
2022-03-31 $285,300 15,000
2021-09-30 $780,520 19,000
2021-06-30 $1,076,160 19,000
2021-03-31 $798,000 19,000
2020-12-31 $1,332,090 19,000
2020-09-30 $533,140 19,000
2020-06-30 $384,540 13,000
2020-03-31 $257,790 13,000